Similar Articles
721 Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
722 Immunotherapy for hepatocellular carcinoma: Current and future
723 Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
724 Hepatocellular carcinoma – time to take the ticket
725 Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
726 Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
727 Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
728 Liver transplantation for hepatocellular carcinoma: Where do we stand?
729 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
730 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA